editorial | Q871232 |
scholarly article | Q13442814 |
P2093 | author name string | George Plataniotis | |
P2860 | cites work | Modeling killing and repopulation kinetics of subclinical cancer: direct calculations from clinical data. | Q30891351 |
Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? | Q33603495 | ||
A shorter fractionation schedule for postlumpectomy breast cancer patients | Q33964210 | ||
Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. | Q34155828 | ||
Time-dose factors in radiotherapy: a review of the human data. | Q34343444 | ||
Adjuvant radiotherapy for early breast cancer: patterns of practice in Ontario. | Q34707063 | ||
Local recurrence of breast cancer following surgery and radiotherapy: incidence and outcome | Q35071917 | ||
Latest developments in local treatment: radiotherapy for early breast cancer | Q36164319 | ||
Moving to a high-tech approach to the irradiation of early breast cancer: is it possible to balance efficacy, morbidity and resource use? | Q36444763 | ||
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. | Q36514573 | ||
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial | Q36571627 | ||
External hypofractionated whole-breast radiotherapy: now where does accelerated partial breast irradiation stand? | Q37083182 | ||
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review | Q37265690 | ||
Accelerated partial breast irradiation trials: diversity in rationale and design | Q37380180 | ||
Biologically effective dose-response relationship for breast cancer treated by conservative surgery and postoperative radiotherapy | Q37558840 | ||
The linear-quadratic formula and progress in fractionated radiotherapy | Q38678064 | ||
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer | Q44230659 | ||
Hypofractionation redux? | Q44900657 | ||
Whole-breast radiotherapy with shorter fractionation schedules following breast-conserving surgery: short-term morbidity and preliminary outcomes | Q46788398 | ||
Long-term results of hypofractionated radiation therapy for breast cancer | Q48887913 | ||
Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. | Q50760966 | ||
Acute toxicity and 2-year adverse effects of 30 Gy in five fractions over 15 days to whole breast after local excision of early breast cancer. | Q51118188 | ||
Hypofractionated radiotherapy for breast cancer patients treated by breast-conserving surgery: short-term morbidity and preliminary results. | Q51836195 | ||
The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. | Q52430649 | ||
Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. | Q53209409 | ||
Adjuvant Hypofractionated Radiation Therapy for Breast Cancer after Conserving Surgery | Q62652641 | ||
Prognostic factors for breast recurrence after conservative breast surgery and radiotherapy: results from a randomised trial | Q71474980 | ||
Late cosmetic results of short fractionation for breast conservation | Q71877343 | ||
Seven-year follow-up on 334 patients treated by breast conserving surgery and short course radical postoperative radiotherapy: a report of the Yorkshire Breast Cancer Group | Q71910013 | ||
Dose-response relationship for radiation therapy of subclinical disease | Q72463949 | ||
The Christie Hospital breast conservation trial: an update at 8 years from inception | Q72766845 | ||
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France | Q73132146 | ||
Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13 | Q73308515 | ||
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group | Q73837095 | ||
Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer | Q78410812 | ||
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial | Q80495823 | ||
P433 | issue | 6 | |
P304 | page(s) | 197-202 | |
P577 | publication date | 2010-06-01 | |
P1433 | published in | World journal of radiology | Q27723340 |
P1476 | title | Hypofractionated radiotherapy in the treatment of early breast cancer | |
P478 | volume | 2 |
Search more.